Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ANIX

Anixa Biosciences Inc

May 29 • 04:00PM ET

2.70

0.00 0.00 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ATYR COYA CYPH INO LONA NRXS CGTX KLRS NRXP KALA

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.32	Insider Own	5.38%	Shs Outstand	33.46M	Perf Week	-1.82%
Market Cap	90.53M	Forward P/E	-	EPS next Y	-0.35	Insider Trans	0.56%	Shs Float	31.72M	Perf Month	-6.25%
Enterprise Value	75.29M	PEG	-	EPS next Q	-0.09	Inst Own	15.23%	Short Float	3.10%	Perf Quarter	-9.40%
Income	-10.31M	P/S	-	EPS this Y	1.47%	Inst Trans	-2.10%	Short Ratio	9.03	Perf Half Y	-37.50%
Sales	0.00M	P/B	5.99	EPS next Y	-4.48%	ROA	-60.39%	Short Interest	0.98M	Perf YTD	-13.46%
Book/sh	0.45	P/C	6.38	EPS next 5Y	-3.32%	ROE	-62.61%	52W High	5.46 -50.52%	Perf Year	3.45%
Cash/sh	0.42	P/FCF	-	EPS past 3/5Y	9.05% 5.67%	ROIC	-67.69%	52W Low	2.44 10.66%	Perf 3Y	-16.15%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.36% 4.99%	Perf 5Y	-31.99%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	19.02%	Oper. Margin	-	ATR (14)	0.14	Perf 10Y	-14.83%
Dividend Ex-Date	-	Quick Ratio	12.18	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	42.06	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	12.18	EPS Q/Q	21.94%	SMA20	-5.74%	Beta	0.60	Target Price	11.50
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-4.22%	Rel Volume	0.86	Prev Close	2.70
Employees	4	LT Debt/Eq	0.01	Earnings	Mar 13	SMA200	-19.01%	Avg Volume	108.84K	Price	2.70
IPO	Oct 07, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.21% -	Trades		Volume	93,663	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)